Antioxidative effect of metformin on valproic acid induced hepatoxicity in male rats

Authors

  • Intesar Tarik Numan Department of Pharmacology and Toxicology, AL-Huda University College, AL Anbar, iraq
  • Nadia Hameed Mohamed Department of Clinical Laboratory Science, College of Pharmacy, Mustansiriyah University
  • Zainab Khalid Ali Department of Pharmacology and Toxicology, College of Pharmacy, Mustansiriyah University

DOI:

https://doi.org/10.32947/ajps.v22i3.885

Abstract

Metformin is 1,1-dimethylbiguanide hydrochloride, is the first-line therapy for type 2 diabetes. Additionally, several studies focused on the role of metformin in antioxidant activities for the treatment of hepatic disorders. The experimentally

 

 -based result on valproic acid's liver injury, a front-line medicine for the treatment of epilepsy, attracted a lot of interest. As a result, the effect of metformin on valproic acid-induced redox disturbances in rat hepatic tissue was studied. metformin at 250 mg/kg dose was administered via oral gavage for 30 days, and valproic acid at a dose of 400 mg/kg was administered by intraperitoneal route starting from the twenty-second day of the experiment, for eight days to induce hepatotoxicity. Treatment with metformin reduced valproic acid-enhancing alanine aminotransferase, aspartate aminotransferase activities. Tissue levels of malondialdehyde in the liver tissue of valproic acid-treated rats significantly increased (P-value < 0.05) whereas glutathione decreased. The coadministration of metformin with valproic acid significantly decreased the malondialdehyde levels and increased glutathione levels (P-value < 0.05). Finally, metformin protected rats from valproic acid-induced hepatotoxicity, improved antioxidant status, and reduced hepatic oxidative stress.

References

- Abdelkader NF, Elyamany M, Gad AM, Assaf N, Fawzy HM, Elesawy WH. Ellagic acid attenuates liver toxicity induced by valproic acid in rats. Journal of Pharmacological Sciences. 2020 May;143(1):23–9. DOI: https://doi.org/10.1016/j.jphs.2020.01.007

- Romoli M, Mazzocchetti P, D’Alonzo R, Siliquini S, Rinaldi VE, Verrotti A, et al. Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences. CN. 2019 Sep 13;17(10):926–46. DOI: https://doi.org/10.2174/1570159X17666181227165722

- Meseguer ES, Elizalde MU, Borobia AM, Ramírez E. Valproic Acid-Induced Liver Injury: A Case-Control Study from a Prospective Pharmacovigilance Program in a Tertiary Hospital. JCM. 2021 Mar 10;10(6):1153. DOI: https://doi.org/10.3390/jcm10061153

- Tong V, Teng XW, Chang TKH, Abbott FS. Valproic Acid II: Effects on Oxidative Stress, Mitochondrial Membrane Potential, and Cytotoxicity in Glutathione-Depleted Rat Hepatocytes. Toxicological Sciences. 2005 Aug 1;86(2):436–43.

- Tong V, Teng XW, Chang TKH, Abbott FS. Valproic Acid I: Time Course of Lipid Peroxidation Biomarkers, Liver Toxicity, and Valproic Acid Metabolite Levels in Rats. Toxicological Sciences. 2005 Aug 1;86(2):427–35. DOI: https://doi.org/10.1093/toxsci/kfi184

- Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: From Mechanisms of Action to Therapies. Cell Metabolism. 2014 Dec;20(6):953–66. DOI: https://doi.org/10.1016/j.cmet.2014.09.018

- Iranshahy M, Rezaee R, Karimi G. Hepatoprotective activity of metformin: A new mission for an old drug? European Journal of Pharmacology. 2019 May; 850:1–7. DOI: https://doi.org/10.1016/j.ejphar.2019.02.004

- Karim LZA, Arif IS, Saady FAA. Metabolomics Of Metformin’s Cardioprotective Effect in Acute Doxorubicin Induced- Cardiotoxicity in Rats. Systematic Reviews in Pharmacy. 2021;12(3):10.

- Kelly B, Tannahill GM, Murphy MP, O’Neill LAJ. Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1β (IL-1β) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages. Journal of Biological Chemistry. 2015 Aug;290(33):20348–59. DOI: https://doi.org/10.1074/jbc.M115.662114

- Rizk FH, El Saadany AA, Dawood L, Elkaliny HH, Sarhan NI, Badawi R, et al. Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone. JIR. 2018 Nov;Volume 11:421–9. DOI: https://doi.org/10.2147/JIR.S178767

- Borole K, Padalkar P, Swami R. Assessment of antioxidant activity of metformin in ethanol induced liver damage in Sprague Dawley rats. Int J Basic Clin Pharmacol. 2016;324–8. DOI: https://doi.org/10.18203/2319-2003.ijbcp20160739

- Struck MB, Andrutis KA, Ramirez HE, Battles AH. Effect of a short-term fast on ketamine-xylazine anesthesia in rats. J Am Assoc Lab Anim Sci JAALAS. 2011 May;50(3):344–8.

- Parasuraman S, Raveendran R, Kesavan R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010;1(2):87–93. DOI: https://doi.org/10.4103/0976-500X.72350

- Shakya R, Hoque MK, Sapkota AS, Gupta PK. Differential Hepatotoxic Effects of Sodium Valproate at Different Doses in Albino Rats. Kathmandu Univ Med J (KUMJ). 2018;16(61):78-82.

- Omidipour R, Zarei L, Boroujeni MB, Rajabzadeh A. Protective Effect of Thyme Honey against Valproic Acid Hepatotoxicity in Wistar Rats. Nabi F, editor. BioMed Research International. 2021 Feb 20; 2021:1–11. DOI: https://doi.org/10.1155/2021/8839898

- Ola OS, Adewole KE. Anticlastogenic and hepatoprotective effects of Kolaviron on sodium valproate-induced oxidative toxicity in Wistar rats. Egyptian Journal of Basic and Applied Sciences. 2021 Jan 1;8(1):167–79. DOI: https://doi.org/10.1080/2314808X.2021.1928974

- Tong V, Teng XW, Chang TKH, Abbott FS. Valproic Acid II: Effects on Oxidative Stress, Mitochondrial Membrane Potential, and Cytotoxicity in Glutathione-Depleted Rat Hepatocytes. Toxicological Sciences. 2005 Aug 1 ;86(2) :436–43. DOI: https://doi.org/10.1093/toxsci/kfi185

- Araújo AA de, Pereira A de SBF, Medeiros CACX de, Brito GA de C, Leitão RF de C, Araújo L de S, et al. Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis. Reddy SV, editor. PLoS ONE. 2017 Aug 28;12(8): e0183506. DOI: https://doi.org/10.1371/journal.pone.0183506

- AL-HASHEM, Fahaid et al. Metformin Protects Against Thioacetamide Induced Liver injury in Rats. Int. J. Morphol. . 2018, 36(3):984-990 DOI: https://doi.org/10.4067/S0717-95022018000300984

- Waleed SR, Wafa AOR, Mohammed TA. Effect of metformin and antioxidant agents on oxidative stress status and follicular maturation in women with polycystic ovary syndrome. AJPS. 2006 Jun 1;3(1):40–5. DOI: https://doi.org/10.32947/ajps.v3i1.406

- Al-Qaisy Y ghanim, Arif IS, Al-ezzi MI. New Perceptions in the Cardioprotective Effect of Metformin Against Isoproterenol Induced Cardiotoxicity in Male Rats. J.port.sci.res. 2021 Apr 10;4(1):23–9. DOI: https://doi.org/10.36371/port.2021.6

Downloads

Published

2022-10-24

How to Cite

Intesar Tarik Numan, Nadia Hameed Mohamed, & Zainab Khalid Ali. (2022). Antioxidative effect of metformin on valproic acid induced hepatoxicity in male rats . Al Mustansiriyah Journal of Pharmaceutical Sciences, 22(3), 17–23. https://doi.org/10.32947/ajps.v22i3.885